BD Kiestra IdentifA— 510(k) K222563

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K222563 for BD Kiestra IdentifA, Substantially Equivalent on 2023-08-31. Applicant: Becton, Dickinson and Company.

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Code QQV
Advisory panel
Microbiology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Sparks, MD, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code QQV

product code QQV
Other
1
Total
1

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.